Continuus Pharmaceuticals Competitors and Similar CompaniesClear all

Umoja Biopharma's competitors and similar companies include ColonaryConcepts, Astria Therapeutics and Zonsen Peplib Biotech.
Umoja Biopharma
Umoja Biopharma
Umoja Biopharma is a company engaged in immunotherapies discovery.
ColonaryConcepts
ColonaryConcepts
ColonaryConcepts is a pharmaceutical development company focused on technology platforms that promote gastrointestinal health.
Astria Therapeutics
Astria Therapeutics
Astria Therapeutics (formerly known as Catabasis Pharmaceuticals) discovers and develops innovative drugs for treating inflammatory conditions.
Zonsen Peplib Biotech
Zonsen Peplib Biotech
Zonsen Peplib Biotech is a platform-based company that develops peptide-leading drugs.
Founding Date
Founding Date
2019
Founding Date
2013
Founding Date
2008
Founding Date
2017
Type
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Seattle, US HQ
Seattle, US
Locations
HQ
Locations
Boston, US HQ
Locations
Zhuzhou, CN HQ
Metuchen, US
Employees
Employees
1951% increase
Employees
3
Employees
2433% decrease
Employees
N/A

Funding

Latest funding round
Latest funding round
$ 210m (about 5 years ago)
Latest funding round
$ 1m (over 8 years ago)
Latest funding round
N/A
Latest funding round
$ 34m (about 5 years ago)
Total funding raised
Total funding raised
$ 263m
Total funding raised
$ 9.9m
Total funding raised
$ 94.9m
Total funding raised
$ 48m
For sources of this data, please see the company profile

View Company Profiles

ColonaryConcepts
HQ
Employees
3

ColonaryConcepts is a pharmaceutical development company focused on technology platforms that promote gastrointestinal health.

View company
Astria Therapeutics
HQ
Boston, US
Employees
24↓ 33% decrease

Astria Therapeutics (formerly known as Catabasis Pharmaceuticals) discovers and develops innovative drugs for treating inflammatory conditions.

View company
Zonsen Peplib Biotech
HQ
Zhuzhou, CN

Zonsen Peplib Biotech is a platform-based company that develops peptide-leading drugs.

View company